Loss of RB and MTS1/CDKN2 (p16) expression in human sarcomas

Human Pathology

Volumn 28, Issue 8, 1997, Pages 893-898

  Cohen, Jill A ^a   Geradts, Joseph ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Fibromatosis; Immunohistochemistry; P16(INK4a); RB protein; Sarcoma; Tumor suppressor genes

Indexed keywords

PROTEIN P16; RETINOBLASTOMA PROTEIN;

ARTICLE; CANCER GRADING; CARCINOGENESIS; CONTROLLED STUDY; FIBROMATOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; SARCOMA; SPINDLE CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 0030824829     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(97)90003-4     Document Type: Article

References (24)

1. Kamb A: Cell cycle regulators and cancer: Trends Genet 11:136-140, 1995
2. INK4a in archival human solid tumors: Correlation with retinoblastoma protein expression. Cancer Res 55:6006-6011, 1995
3. INK4a cyclin dependent kinase inhibitor in malignant mesothelioma. J Natl Cancer Inst 87:1870-1875, 1995
4. Caldas C, Hahn SA, daCosta LT, et al: Frequent somatic mutations and homozygous deletions of p16(MTS1) gene in pancreatic adenocarcinoma. Nat Genet 8:27-32, 1994
5. Schmidt EE, Ichimura K, Reifenberger G, et al: CDKN2 (p16/ S1) gene deletion or CDK4 amplification occurs in the majority of glioblastoma. Cancer Res 54:6321-6324, 1994
6. INK4a protein is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene 9:3375-3378, 1994
7. Draper GJ, Sanders BM, Kingston JE: Second primary neoplasms in patients with retinoblastoma. BrJ Cancer 53:661-671, 1986
8. Serrano M, Lee H, Chin L, et al: Role of the INK4a locus in tumor suppression and cell mortality. Cell 85:27-37, 1996
9. Coindre JM, Trojani M, Contesso G, et al: Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer 58:306-309, 1986
10. Wen SF, Nodelman M, Nared-Hood K, et al: Retinoblastoma protein monoclonal antibodies with novel characteristics. J Immunol Methods 169:231-240, 1994
11. INK4a expression in resected non-small cell lung tumors. Cancer Res 56:3415-3420, 1996
12. INK4a expression in human breast cancer. AmJ Pathol 149:1-6, 1996
13. Miller CW, Aslo A, Campbell MJ, et al: Alterations of the p15, p16 and p18 genes in osteosarcoma. Cancer Genet Cytogenet 86:136-142, 1996
14. Stratton MR, Moss S, Warren W, et al: Mutation of the p53 gene in human soft tissue sarcomas: Association with abnormalities of the RB1 gene. Oncogene 5:1297-1301, 1990
15. Maelandsmo GM, Berner JM, Florenes VA, et al: Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas - relationship to amplification and mRNA levels of CDK4 and CCND1. Br J Cancer 72:393-398, 1995
16. Dei Tos AP, Maestro R, Doglioni C, et al: Tumor suppressor genes and related molecules in leiomyosarcoma. Am J Pathol 148:1037-1045, 1996
17. Cance WG, Brennan MF, Dudas ME, et al: Altered expression of the retinoblastoma gene product in human sarcomas. N Engl J Med 323:1457-1462, 1990
18. Karpeh MS, Brennan MF, Cance WG, et al: Altered patterns of retinoblastoma gene expression in adult soft-tissue sarcomas. Br J Cancer 72:986-991, 1995
19. RB tumor suppressor gene expression in human soft tissue tumors: Correlations with cell proliferation and tumor grade. Mod Pathol 8:837-842
20. Reed JA, Loganzo F Jr, Shea CR, et al: Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression. Cancer Res 55:2713-2718, 1995
21. Bartsch D, Shevlin DW, Callery MP, et al: Reduced survival in patients with ductal pancreatic adenocarcinoma associated with CDKN2 mutation. J Natl Cancer Institute 88:680-681, 1996
22. Li W, Fan J, Hochhauser D, et al: Lack of functional retinoblastoma protein mediates increased resistance to antimetabolites in human sarcoma cell lines. Proc Natl Acad Sci USA 92:10436-10440, 1995
23. Lauer E, Yandell D, Castagnaro M, et al: Molecular genetic and immunohistochemical analysis of tumor suppressor genes p53 and RB in fibromatosis. Mod Pathol 6:8, 1993 (abstr)
24. Geradts J, Kratzke RA, Crush-Stanton S, et al: Wild type and mutant retinoblastoma protein in paraffin sections. Mod Pathol 9:339-347, 1996